K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder

SUMMARY The human fibroblast growth factor receptor 3 (FGFR3) gene is frequently mutated in superficial urothelial cell carcinoma (UCC). To test the functional significance of FGFR3 activating mutations as a ‘driver’ of UCC, we targeted the expression of mutated Fgfr3 to the murine urothelium using...

Full description

Bibliographic Details
Main Authors: Imran Ahmad, Lukram Babloo Singh, Mona Foth, Carol-Ann Morris, Makoto Mark Taketo, Xue-Ru Wu, Hing Y. Leung, Owen J. Sansom, Tomoko Iwata
Format: Article
Language:English
Published: The Company of Biologists 2011-07-01
Series:Disease Models & Mechanisms
Online Access:http://dmm.biologists.org/content/4/4/548
id doaj-4cb9c5d92474456da4eabdd48f5bb905
record_format Article
spelling doaj-4cb9c5d92474456da4eabdd48f5bb9052020-11-25T00:11:42ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112011-07-014454855510.1242/dmm.006874006874K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladderImran AhmadLukram Babloo SinghMona FothCarol-Ann MorrisMakoto Mark TaketoXue-Ru WuHing Y. LeungOwen J. SansomTomoko IwataSUMMARY The human fibroblast growth factor receptor 3 (FGFR3) gene is frequently mutated in superficial urothelial cell carcinoma (UCC). To test the functional significance of FGFR3 activating mutations as a ‘driver’ of UCC, we targeted the expression of mutated Fgfr3 to the murine urothelium using Cre-loxP recombination driven by the uroplakin II promoter. The introduction of the Fgfr3 mutations resulted in no obvious effect on tumorigenesis up to 18 months of age. Furthermore, even when the Fgfr3 mutations were introduced together with K-Ras or β-catenin (Ctnnb1) activating mutations, no urothelial dysplasia or UCC was observed. Interestingly, however, owing to a sporadic ectopic Cre recombinase expression in the skin and lung of these mice, Fgfr3 mutation caused papilloma and promoted lung tumorigenesis in cooperation with K-Ras and β-catenin activation, respectively. These results indicate that activation of FGFR3 can cooperate with other mutations to drive tumorigenesis in a context-dependent manner, and support the hypothesis that activation of FGFR3 signaling contributes to human cancer.http://dmm.biologists.org/content/4/4/548
collection DOAJ
language English
format Article
sources DOAJ
author Imran Ahmad
Lukram Babloo Singh
Mona Foth
Carol-Ann Morris
Makoto Mark Taketo
Xue-Ru Wu
Hing Y. Leung
Owen J. Sansom
Tomoko Iwata
spellingShingle Imran Ahmad
Lukram Babloo Singh
Mona Foth
Carol-Ann Morris
Makoto Mark Taketo
Xue-Ru Wu
Hing Y. Leung
Owen J. Sansom
Tomoko Iwata
K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder
Disease Models & Mechanisms
author_facet Imran Ahmad
Lukram Babloo Singh
Mona Foth
Carol-Ann Morris
Makoto Mark Taketo
Xue-Ru Wu
Hing Y. Leung
Owen J. Sansom
Tomoko Iwata
author_sort Imran Ahmad
title K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder
title_short K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder
title_full K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder
title_fullStr K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder
title_full_unstemmed K-Ras and β-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder
title_sort k-ras and β-catenin mutations cooperate with fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder
publisher The Company of Biologists
series Disease Models & Mechanisms
issn 1754-8403
1754-8411
publishDate 2011-07-01
description SUMMARY The human fibroblast growth factor receptor 3 (FGFR3) gene is frequently mutated in superficial urothelial cell carcinoma (UCC). To test the functional significance of FGFR3 activating mutations as a ‘driver’ of UCC, we targeted the expression of mutated Fgfr3 to the murine urothelium using Cre-loxP recombination driven by the uroplakin II promoter. The introduction of the Fgfr3 mutations resulted in no obvious effect on tumorigenesis up to 18 months of age. Furthermore, even when the Fgfr3 mutations were introduced together with K-Ras or β-catenin (Ctnnb1) activating mutations, no urothelial dysplasia or UCC was observed. Interestingly, however, owing to a sporadic ectopic Cre recombinase expression in the skin and lung of these mice, Fgfr3 mutation caused papilloma and promoted lung tumorigenesis in cooperation with K-Ras and β-catenin activation, respectively. These results indicate that activation of FGFR3 can cooperate with other mutations to drive tumorigenesis in a context-dependent manner, and support the hypothesis that activation of FGFR3 signaling contributes to human cancer.
url http://dmm.biologists.org/content/4/4/548
work_keys_str_mv AT imranahmad krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder
AT lukrambabloosingh krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder
AT monafoth krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder
AT carolannmorris krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder
AT makotomarktaketo krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder
AT xueruwu krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder
AT hingyleung krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder
AT owenjsansom krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder
AT tomokoiwata krasandbcateninmutationscooperatewithfgfr3mutationsinmicetopromotetumorigenesisintheskinandlungbutnotinthebladder
_version_ 1725402677079179264